Kazia Therapeutics Ltd Sponsored ADR (KZIA)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
12. 71
-1.06
-7.7342%
$
22.3M Market Cap
- P/E Ratio
- Div Yield
1.21M Volume
0 Eps
$ 13.77
Previous Close 
Want to track KZIA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kazia Therapeutics Ltd Sponsored ADR (KZIA) Statistics
Valuation metrics
Market Cap 22.3M
Enterprise value -38.59M
Trailing P/E (ttm) -1.83
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 1,557.74
Price/Book (mrq) 1.27
Enterprise Value/Revenue -1,957.85
Enterprise Value/EBITDA 2.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 381.31K
Average volume (90 days) 261.92K
Price summary
52-Week low 4.86
52-Week high 17.4
Beta -
50-Day moving average 13.8
200-Day moving average 10.41
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 25 Jan 2013
Ex-Dividend Date 28 Jan 2013
Last split factor 1:5
Last split Date 17 Apr 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1,130.05%
Operating margin -920.86%
Operational effectiveness
Return on assets -0.31%
Return on equity -1.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 22.24
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 2.87%
Book value per share (mrq) 14.88
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
